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Bone tissue engineering scaffolds have two challenging functional tasks to play; to be
bioactive by encouraging cell proliferation and differentiation, and to provide suitable
mechanical stability upon implantation. Composites of biopolymers and bioceramics
unite the advantages of both materials, resulting in better processability, enhanced
mechanical properties through matrix reinforcement and osteoinductivity. Novel compo-
site blends of poly(L-lactide-co-D,L-lactide)/tricalcium phosphate (PLDLLA/TCP) were
fabricated into scaffolds by an extrusion deposition technique customised from standard
rapid prototyping technology. PLDLLA/TCP composite material blends of various
compositions were prepared and analysed for their mechanical properties. PLDLLA/TCP
(10%) was optimised and fabricated into scaffolds. Compressive mechanical properties for
the composite scaffolds were measured. In vitro studies were conducted using porcine
bone-marrow stromal cells (BMSCs). Cell-scaffold constructs were induced using
osteogenic induction factors for up to 8 weeks. Cell proliferation, viability and
differentiation capabilities were assayed using phase-contrast light microscopy, scanning
electron microscopy, DNA quantification (Pico Green), Alamar Blue metabolic assay;
FDA/PI fluorescent assay and western blot analysis for osteopontin. Microscopy
observations showed BMSCs possessed high proliferative capabilities and demonstrated
bridging across the pores of the scaffolds. FDA/PI staining as well as Alamar Blue assay
showed high viability of BMSCs cultured on the composite scaffolds. Cell numbers, based
on DNA quantitation, were observed to increase continuously up to the eighth week of
study. Western blot analysis showed increased osteopontin synthesis on the scaffolds
compared to tissue culture plastic. Based on our results the PLDLLA/TCP scaffolds
exhibited good potential and biocompatibility for bone tissue engineering applications.
Keywords: composite; bioresorbable scaffolds; PLDLLA; tissue engineering; bone
1. Introduction
This paper describes the physical prototyping of bone,
which may eventually lead to the manufacture of replace-
ment bone tissue. In the clinical setting, bone graft
substitutes are commonly used in the treatment of bone
injuries and diseases where the host bone tissue is removed
or needed to be excised. Although autogenous and alloge-
neous bone can be used as bone grafts but they also entail
shortcomings such as donor site morbidity, limited quan-
tity, immune response and pathogen transfer. The demand
for alternative bone graft substitutes has been growing,
especially with the increasingly active and ageing popula-
tion. Development of an effective bone graft substitute is
paramount for the repair of bone defects and fractures;
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revision surgeries should be avoided as they would lead to
higher risks and costs.
Some major drawbacks associated with bone regenera-
tion are the lack of a suitable scaffold with properties to
meet the mechanical and functional requirements at the
defect site. An ideal scaffold should be biocompatible,
bioresorbable, able to retain the shape and structure of the
defect site while providing mechanical support, be porous
and osteoconductive for bone regeneration to occur
(Hutmacher 2000, Hutmacher et al. 2007). It should also
be a suitable carrier for cells or growth factors which could
be included to enhance the bone regeneration therapy.
Bone tissue engineering scaffolds made of polymers or
ceramic have been extensively reported (De Groot et al.
1997, Ishaug et al. 1997, Chistolini et al. 1999, Chu et al.
2002, Ramay and Zhang 2004). However, polymers and
ceramics individually have several shortcomings, and by
creating polymer-ceramic composite scaffolds, advanta-
geous properties from both materials could be harnessed
to improve on mechanical and biological properties to
improve cell proliferation and differentiation (Liao et al.
2005, Kim 2007, Schumann et al. 2007, Zhou et al. 2007).
Novel composite blends of poly(L-lactide-co-D,L-lactide)/
tricalcium phosphate (PLDLLA/TCP) were fabricated into
scaffolds by an extrusion deposition technique customised
from standard rapid prototyping technology.
2. Materials and methods
Polylactide (PLA) generally has superior mechanical prop-
erties as compared to polycaprolactone (PCL), and has
vastly different degradation rates and processability chal-
lenges. Tricalcium phosphate bioceramic is a common and
typical bone filler material used in bone grafting. Compo-
site scaffolds were intricately designed and fabricated with
these novel biopolymer-bioceramic composite materials
with superior mechanical properties (Hutmacher 2007).
Poly(L-lactide-co-D,L-lactide) (PLDLLA) was purchased
from Boehringer Ingelheim GmbH and b-tricalcium
phosphate (TCP) from Progentix BV.
A composite material blend was mixed together using an
in-house, robotically mounted screw-extruder system and
various compositions were prepared for the pilot material
analysis. The particle size distribution of the TCP particu-
lates was determined on a laser diffraction particle size
analyser (Partica LA-950, Horiba; range 0.013000 mm)
with an average size of 15 mm. This novel composite blend
was prepared into standard dog-bone shaped specimens for
tensile tests by injection moulding.
An in-house rapid prototyping (RP) system, namely the
screw extrusion system (SES), was developed between
Temasek Polytechnic, Singapore (TP), and the National
University of Singapore (NUS). This customised system
allows for exploratory novel polymeric-based materials to
be extruded into porous three-dimensional (3D) scaffolds.
The deposition principle of the SES is similar to the fused
deposition modelling (FDM) method (Hutmacher et al.
2001, Zein et al. 2002, Hutmacher 2007). Scaffolds are built
using a lattice pattern where individual extruded paths, or
‘roads’, are separate from each other laterally. This is
helpful in the cell-growing phase of the process but also
simplifies the software and control requirements for
designing and building the scaffolds.
Scaffolds of different material compositions were fabri-
cated using the SES. Test blocks of each composition (size
5510 mm3) were cut from larger blocks that were
fabricated with a 0908 lay-down pattern, for mechanical
studies. The build geometry and porosity were kept as
constant as possible for each material composition. Tensile
and compression tests were conducted on an Instron 4302
Material Testing System, operated by Series IX Automated
Materials Tester v. 7.43 system software, with a 1 kN load
cell. For the tensile test, the specimens were pulled in
tension at a rate of 1 mm/min until break, while for the
compression test the compression rate was 1 mm/min up to
a strain level of 0.6. The stressstrain (so) curves were
obtained to evaluate the elastic/stiffness (modulus) and
compressive yield strength of the scaffolds. The modulus
was calculated from the stressstrain curve as the slope of
the initial linear portion of the curve, with any toe region
from the initial settling of the specimen neglected. A sample
size of n5 was tested for each group.
Thinner scaffold sheets of 554 mm3 with a 060
1208 lay-down pattern were also prepared for the in vitro
cell culture study. The scaffolds were treated with 5 M
sodium hydroxide for 10 minutes and rinsed with five
changes of de-ionised water; this would yield a more
hydrophilic and corrugated material surface which, along
with the more complex geometrical structure of the
scaffold, is more beneficial for cell culturing. The scaffolds
were then sterilized in 70% ethanol for 2 hours and under
UV light for 20 minutes for each side.
Each scaffold was seeded with 100,000 primary porcine
bone marrow stem cells (BMSC) expanded from our frozen
stock (passage 34) in growth media: Dulbecco’s Modified
Eagle medium (DMEM) with 10% fetal bovine serum
(FBS), 1% penicillin and 1% streptomycin (all from Gibco).
The seeded cells were cultured up to 8 weeks in static
culture supplemented with osteogenic media consisting of
DMEM growth media with 10 nM dexamethasome, 50 mM
ascorbic acid 2 phosphate and 10 mM -glycerolphosphate
(all from Sigma).
The cell-scaffold constructs were observed and analysed
at various time points with phase-contrast light, confocal
laser microscopy (CLM) and scanning electron microscopy
(SEM). The proliferation of the BMSCs intercellular
development and extracellular matrix production was
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examined every few days with phase-contrast light micro-
scopy. For CLM analysis, the cells within the scaffold
construct were stained using a fluorescent dye, fluorescein
diacetate (FDA) and propidium iodide (PI) (both from
Molecular Probes Inc). After uptake of the FDA dye, the
samples were then rinsed twice in PBS and stained with the
PI dye, after which they were finally rinsed twice in PBS and
viewed under a confocal laser microscope (Olympus IX
70-HLSH100 Fluoview). Depth projection images were
constructed from up to 25 horizontal image sections
through the 3D scaffold construct. Viable cells were stained
green (FDA) while apoptotic cells were stained red (PI).
After CLM observations, the samples were fixed in 3.7%
formaldehyde. The sample was subsequently dehydrated
over a graded ethanol series and samples were gold-
sputtered for SEM observation at 15 kV accelerating
voltage (Philips XL30 FEG).
The composite cell construct was also analysed using the
AlamarBlue metabolic assay and PicoGreen dsDNA quan-
tification assay, to investigate the metabolic activity and cell
proliferation over various time points. The levels of speci-
men metabolic activity (n5) were quantified via the
AlamarBlue assay (Biosource). At each time point, culture
medium was aspirated from each construct-containing well
and mixed with 5% AlamarBlue reagent. The mixture was
incubated for 2 h at 378C in the incubator and absorbance
was measured on a plate reader (Safire2Tecan) at wave-
lengths of 560 nm and 600 nm, together with blank controls
using medium with reagent and medium only. Cell-con-
struct metabolic activity was directly correlated to the
percentage reduction of AlamarBlue reagent by the
cells, calculated based on the manufacturer’s protocol
(www.biosource.com). Cell proliferation in the specimens
(n5) was evaluated using the PicoGreen dsDNA quanti-
fication assay (Molecular Probes Inc). At selected time
points, specimens were subjected to freeze-thaw cycles of 1
hour each (between -808C and 378C) for three cycles to
break up the cell and nuclear membranes to obtain a
homogenous cell suspension. PicoGreen working solution
(100 ml) was added to 100 ml of specimen and incubated at
room temperature for 5 minutes. Fluorescence was then
measured with a plate reader (Safire2Tecan) at excitation
and emission wavelengths of 480 nm and 520 nm, respec-
tively. The amount of DNA was calculated by extrapolating
a standard curve obtained by running the assay with the
provided dsDNA standard.
Western blot analysis was performed to observe the
presence of osteogenic proteins synthesised in the con-
structs. Proteins from each specimen were isolated in a lysis
buffer (5 mM MgCl2, 150 mM NaCl, 1% Triton-100, pH
7.5) at 48C for 20 minutes after rinsing in cold PBS three
times. Lysates were collected after centrifugation at
12,000g at 48C, for 5 minutes. The total amount of
protein obtained was quantified with the Micro BCA kit
(Pierce) with a standard curve derived from bovine serum
albumin (Sigma). Polyacrylamide gel electrophoresis
(SDS-PAGE) was performed and the separated proteins
were then transferred to nitrocellulose membranes and
incubated with rabbit anti-human osteopontin antibody
(OPN-Abcam) and rabbit anti human b-actin (Delta
Biolabs) as control. The protein bands on the membrane
were detected by chemiluminescence (SuperSignal West
Pico-Pierce) and the intensity was measured with a densit-
ometer (BioRad VersaDoc 5000).
3. Results and discussions
The tensile test of the composite material with increasing
percentage of TCP revealed that reinforcing the polymer
matrix resulted in an increase of stiffness for the new
composite material (Figure 1). However, with higher TCP
contents the processability of the material becomes a
challenge as the overall viscosity of the material increases.
The SES fabricated PLDLLA/TCP (10%) scaffolds have
a highly porous three-dimensional structure manufactured
by the deposition of individual layers of struts at two angles
(Figure 2). Gross morphological observations show good
strut fusion between the layers, homogeneity and consis-
tency of the deposited struts (average diameter 400mm).
The pores created were also regular and coherent to the
design. The scaffold gross morphology had a neat spatial
arrangement of pores and channels which were fully
interconnected throughout the whole scaffold.
The compression tests revealed that the two-angled
scaffold design (0908) had a compressive stiffness of about
80 MPa and a maximum compressive strength of 3 MPa
(Figure 3). These values are in the range of normal
cancellous bone, which has a reported stiffness of 90400
MPa and strength of 25 MPa (Athanasiou et al. 2000).
These mechanical properties indicate the potential applica-
tion of these scaffolds in the field of bone engineering. For
load-bearing tissues, especially bone and cartilage, the 3D
scaffold platform should be bioresorbable and provide
Figure 1. Modulus of dumb-bell-shaped test specimen of
PLDLLA and composite PLDLLA/TCP.
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adequate mechanical stability over the required time to
withstand in vivo conditions.
Whilst the 0908 configuration yields good mechanical
results and is suitable for initial investigations, there are two
primary reasons why this configuration is not suitable for
building practical scaffolds. First, the compression and
tensile behaviour is acceptable only when loaded in the
build direction of the scaffold. Should a load be applied at
an angle, the scaffold is likely to collapse at a much lower
load. Second, the simple through geometry of the rectan-
gular scaffolds is not conducive to cell attachment, with
many cells passing through the scaffold entirely. A more
complex geometry (like the 0608-1208 pattern of the later
experiments) must therefore be used, which allows better
trapping of cells and can distribute the load more evenly in
all directions.
Scaffold interconnectivity and porosity are essential for
cell proliferation and exchange of nutrient and waste
products (Hutmacher 2000). Their effects and relation to
mechanical stability have also been clearly defined. As
porosity increases, with the consequential decrease in
scaffold material, its mechanical properties would suffer
correspondingly. Zein et al. (2002) and Lam et al. (2007)
have demonstrated the dependence of mechanical proper-
ties on scaffold porosity when designing and fabricating
scaffolds via rapid prototyping. The relationship of increas-
ing porosity and declining mechanical properties has been
found to follow a power law relationship (Gibson and
Ashby 1997). The high dependence of mechanical proper-
ties on scaffold porosity had also been reported by
Thomson et al. (1995) and De Groot et al. (1997).
Reinforcement through incorporation of filler material
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Figure 3. Compression stiffness (modulus) and maximum
strength of the PLDLLA/TCP scaffolds. Arrowed and
bulbed indicators indicate range of values for cancellous
bone (Athanasiou et al. 2000).
Figure 2. Plan view of an SEM micrograph of a three-angle
scaffold with picture of a two-angle scaffold inset (top
right).
Figure 4. Composite pictures of PLDLLA/TCP scaffold on
a graph showing the observed AlamarBlue relative fluores-
cence readings, metabolic activity on the uptrend; dipping
slightly after day 28 and continuing to increase shortly after.
Inset images: microscope image at day 28; pBMSC has
proliferated and formed dense sheets adhering to the
PLDLLA/TCP scaffold struts and structures. They also
form bridging over the open pores (Top). Confocal micro-
scope image showing majority of viable cells (green) already
bridging the pores at day 14; dead cells would fluoresce red
(none observed) (bottom left). SEM image at day 28
showing dense cell sheets spread over the pores and struts
of the scaffold architecture (bottom right).
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into the polymer matrix is one alternative method of
increasing the mechanical properties.
Cell-scaffold constructs cultured in static conditions up
to 8 weeks showed a promising scaffold with suitable
surface characteristics and architecture for cell proliferation
and growth. AlamarBlue assay revealed increasing meta-
bolic activity from day 0 to day 28, when the peak was
reached (Figure 4). Phase-contrast microscope observation
and SEM observations corroborated the cell proliferation
in the scaffold and forming layers and sheets covering the
scaffold struts and bridging the pores (Figure 4). Confocal
laser microscope observations confirmed the cell morphol-
ogy and distribution of viable cells in the cell-scaffold
construct. DNA quantification with the PicoGreen assay
also confirmed the increase in cell population. Subsequent
western blot analysis for osteopontin revealed the presence
of the osteo-protein, indicating the differentiation capability
and plasticity of the BMSCs on the composite scaffolds.
4. Conclusions and further work
These results have demonstrated that the PLDLLA/TCP
scaffolds exhibited good biocompatibility and potential, for
both functional mechanical and biological role require-
ments, as a scaffold for bone tissue engineering applications
or bone graft substitute. Further work is being conducted
to increase the mechanical properties of the composite
system and to promote cell attachment and growth.
Different binders and other techniques for improving the
interface between the polymer and ceramic particles are
being experimented with that should further increase the
mechanical properties. Furthermore, coatings and attach-
ment of bioactive agents are being experimented to
determine if they could increase the cell attachment and
growth, which should further shorten the bone growth
phase and maintain good mechanical properties in vivo.
Scaffolds are already available for non-load-bearing
application areas. By improving the mechanical behaviour
of the scaffolds so that they can stay stronger for longer
periods whilst the new bone cells strengthen themselves, we
stand a chance of eventually creating load-bearing bones.
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